ID

26341

Beskrivning

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Survival

Nyckelord

Versioner (6)
  1. 2017-10-10 2017-10-10 -
  2. 2017-10-10 2017-10-10 -
  3. 2017-10-16 2017-10-16 -
  4. 2017-10-16 2017-10-16 -
  5. 2017-10-23 2017-10-23 -
  6. 2018-01-11 2018-01-11 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

16 oktober 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Survival GSK study Chronic Coronary Heart Disease NCT00799903

Engelsk

Survival Identification GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulär  
Survival data
Beskrivning

Survival data

1. Subject status
Beskrivning

Subject status

Datatyp

integer

If subject known to be alive: Subject known to be alive on (date)
Beskrivning

Date Subject known to be alive

Datatyp

date

If subject known to be alive: Source of information
Beskrivning

Subject alive Source of information

Datatyp

text

If subject died: date that site acquired death information
Beskrivning

date that site acquired death information

Datatyp

date

If subject died: Source of information
Beskrivning

death of subject Source of information

Datatyp

text

If no new Survival Status data available: Date of most recent attempt to assess survival status
Beskrivning

Date of most recent attempt to assess survival status

Datatyp

date

Tillbaka till toppen

Similar models

Survival Identification GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Survival data
Item
1. Subject status
integer
Subject status
Code List
1. Subject status
CL Item
Subject known to be alive (1)
CL Item
Subject died (2)
CL Item
No new Survival Status data available for this subject since the last data were collected (3)
Date Subject known to be alive
Item
If subject known to be alive: Subject known to be alive on (date)
date
Item
If subject known to be alive: Source of information
text
Subject alive Source of information
Code List
If subject known to be alive: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (e.g., newspaper, newsletter, featured in a performance, award, or interview, etc) (3)
CL Item
Other (OT)
date that site acquired death information
Item
If subject died: date that site acquired death information
date
Item
If subject died: Source of information
text
Subject alive Source of information
Code List
If subject died: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (e.g., newspaper, newsletter, featured in a performance, award, or interview, etc) (3)
CL Item
Other (OT)
Date of most recent attempt to assess survival status
Item
If no new Survival Status data available: Date of most recent attempt to assess survival status
date
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial